Yunkang Group Limited (HKG:2325)
Hong Kong · Delayed Price · Currency is HKD 0.6050
-0.0350 (-5.47%)
Aug 21, 2026, 4:08 PM HKT
Yunkang Group Market Cap
Yunkang Group has a market cap or net worth of 354.13 million as of August 21, 2026. Its market cap has decreased by -74.90% in one year.
Market Cap
354.13M
Enterprise Value
-763.69M
Revenue
669.23M
Ranking
n/a
PE Ratio
109.00
Stock Price
0.61
ChartMarket Cap Chart
Since May 18, 2022, Yunkang Group's market cap has decreased from 5.21B to 354.13M, a decrease of -93.21%. That is a compound annual growth rate of -46.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 354.13M | -38.89% |
| Dec 31, 2025 | 579.49M | -89.52% |
| Dec 31, 2024 | 5.53B | -25.83% |
| Dec 29, 2023 | 7.46B | -25.55% |
| Dec 30, 2022 | 10.01B | 92.14% |
| May 18, 2022 | 5.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi XDC Cayman | 88.90B |
| Adicon Holdings | 2.53B |
| Guanze Medical Information Industry (Holding) | 2.19B |
| Mega Genomics | 1.59B |
| Kindstar Globalgene Technology | 952.24M |
| China Biotech Services Holdings | 600.07M |
| Biosino Bio-Technology and Science Incorporation | 458.00M |
| Zhong Ji Longevity Science Group | 311.96M |